AAAAAA
Results: 1-25/115
Authors:
ELMAN I
GOLDSTEIN DS
EISENHOFER G
FOLIO J
MALHOTRA AK
ADLER CM
PICKAR D
BREIER A
Citation: I. Elman et al., MECHANISM OF PERIPHERAL NORADRENERGIC STIMULATION BY CLOZAPINE, Neuropsychopharmacology, 20(1), 1999, pp. 29-34
Authors:
MALHOTRA AK
GOLDMAN D
MAZZANTI C
CLIFTON A
BREIER A
PICKAR D
Citation: Ak. Malhotra et al., A FUNCTIONAL SEROTONIN TRANSPORTER (5-HTT) POLYMORPHISM IS ASSOCIATEDWITH PSYCHOSIS IN NEUROLEPTIC-FREE SCHIZOPHRENICS, Molecular psychiatry, 3(4), 1998, pp. 328-332
Authors:
PICKAR D
Citation: D. Pickar, THE D-2 RECEPTOR - LOVE IT AND LEAVE IT, Molecular psychiatry, 3(2), 1998, pp. 101-102
Authors:
MALHOTRA AK
GOLDMAN D
BUCHANAN RW
ROONEY W
CLIFTON A
KOSMIDIS MH
BREIER A
PICKAR D
Citation: Ak. Malhotra et al., THE DOPAMINE D-3 RECEPTOR (DRD3) SER(9)GLY POLYMORPHISM AND SCHIZOPHRENIA - A HAPLOTYPE RELATIVE RISK STUDY AND ASSOCIATION WITH CLOZAPINE RESPONSE, Molecular psychiatry, 3(1), 1998, pp. 72-75
Authors:
PINALS DA
MALHOTRA AK
BREIER A
PICKAR D
Citation: Da. Pinals et al., INFORMED CONSENT IN SCHIZOPHRENIA RESEARCH, Psychiatric services, 49(2), 1998, pp. 244-244
Authors:
ELMAN I
GOLDSTEIN DS
HOLMES C
PICKAR D
FOLIO J
ADLER C
BREIER A
Citation: I. Elman et al., MECHANISM OF PERIPHERAL NORADRENERGIC STIMULATION BY CLOZAPINE, Schizophrenia research, 29(1-2), 1998, pp. 143-143
Authors:
RAEDLER TJ
KNABLE MB
LAFARGUE T
PICKAR D
WEINBERGER DR
Citation: Tj. Raedler et al., STRIATAL DOPAMINE D2 RECEPTOR OCCUPANCY IN PATIENTS TREATED WITH OLANZAPINE, Schizophrenia research, 29(1-2), 1998, pp. 166-166
Authors:
MALHOTRA AK
BREIER A
GOLDMAN D
PICKEN L
PICKAR D
Citation: Ak. Malhotra et al., THE APOLIPOPROTEIN-E EPSILON-4 ALLELE IS ASSOCIATED WITH BLUNTING OF KETAMINE-INDUCED PSYCHOSIS IN SCHIZOPHRENIA - A PRELIMINARY-REPORT, Neuropsychopharmacology, 19(5), 1998, pp. 445-448
Authors:
COHEN RM
NORDAHL TE
SEMPLE WE
ANDREASON P
PICKAR D
Citation: Rm. Cohen et al., ABNORMALITIES IN THE DISTRIBUTED NETWORK OF SUSTAINED ATTENTION PREDICT NEUROLEPTIC TREATMENT RESPONSE IN SCHIZOPHRENIA, Neuropsychopharmacology, 19(1), 1998, pp. 36-47
Authors:
BREIER A
ADLER CM
WEISENFELD N
SU TP
ELMAN I
PICKEN L
MALHOTRA AK
PICKAR D
Citation: A. Breier et al., EFFECTS OF NMDA ANTAGONISM ON STRIATAL DOPAMINE RELEASE IN HEALTHY-SUBJECTS - APPLICATION OF A NOVEL PET APPROACH, Synapse, 29(2), 1998, pp. 142-147
Authors:
MURPHY DL
KAROUM F
PICKAR D
COHEN RM
LIPPER S
MELLOW AM
TARIOT PN
SUNDERLAND T
Citation: Dl. Murphy et al., DIFFERENTIAL TRACE AMINE ALTERATIONS IN INDIVIDUALS RECEIVING ACETYLENIC INHIBITORS OF MAO-A (CLORGYLINE) OR MAO-B (SELEGILINE AND PARGYLINE), Journal of neural transmission. Supplementum, (52), 1998, pp. 39-48
Authors:
MELTZER HY
CASEY DE
GARVER DL
MARDER SR
MASAND PS
MILLER D
PICKAR D
TANDON R
Citation: Hy. Meltzer et al., MEASURING OUTCOME IN SCHIZOPHRENIA - DIFFERENCES AMONG THE ATYPICAL ANTIPSYCHOTICS, The Journal of clinical psychiatry, 59, 1998, pp. 3-9
Authors:
MELTZER HY
CASEY DE
GARVER DL
LASAGNA L
MARDER SR
MASAND PS
MILLER D
PICKAR D
TANDON R
Citation: Hy. Meltzer et al., CLINICAL DEVELOPMENT OF ATYPICAL ANTIPSYCHOTICS - RESEARCH DESIGN ANDEVALUATION, The Journal of clinical psychiatry, 59, 1998, pp. 10-16
Authors:
MELTZER HY
CASEY DE
GARVER DL
LASAGNA L
MARDER SR
MASAND PS
MILLER D
PICKAR D
TANDON R
Citation: Hy. Meltzer et al., ADVERSE-EFFECTS OF THE ATYPICAL ANTIPSYCHOTICS, The Journal of clinical psychiatry, 59, 1998, pp. 17-22
Authors:
MELTZER HY
CASEY DE
GARVER DL
LASAGNA S
MARDER SR
MASAND PS
MILLER D
PICKAR D
TANDON R
Citation: Hy. Meltzer et al., ASSESSMENT OF EPS AND TARDIVE-DYSKINESIA IN CLINICAL-TRIALS, The Journal of clinical psychiatry, 59, 1998, pp. 23-27
Authors:
MELTZER HY
CASEY DE
GARVER DL
MARDER SR
MASAND PS
MILLER D
PICKAR D
TANDON R
Citation: Hy. Meltzer et al., ASSESSING THE EFFECTS OF ATYPICAL ANTIPSYCHOTICS ON NEGATIVE SYMPTOMS, The Journal of clinical psychiatry, 59, 1998, pp. 28-34
Authors:
MELTZER HY
CASEY DE
GARVER DL
LASAGNA L
MARDER SR
MASAND PS
MILLER D
PICKAR D
TANDON R
Citation: Hy. Meltzer et al., EVALUATING THE EFFECTS OF ANTIPSYCHOTICS ON COGNITION IN SCHIZOPHRENIA, The Journal of clinical psychiatry, 59, 1998, pp. 35-40
Authors:
MELTZER HY
CASEY DE
GARVER DL
LASAGNA L
MARDER SR
MASAND PS
MILLER D
PICKAR D
TANDON R
Citation: Hy. Meltzer et al., ATYPICAL ANTIPSYCHOTICS FOR TREATMENT OF DEPRESSION IN SCHIZOPHRENIA AND AFFECTIVE-DISORDERS, The Journal of clinical psychiatry, 59, 1998, pp. 41-45
Authors:
MELTZER HY
CASEY DE
GARVER DL
LASAGNA L
MARDER SR
MASAND PS
MILLER D
PICKAR D
TANDON R
Citation: Hy. Meltzer et al., TREATMENT OF SPECIAL POPULATIONS WITH THE ATYPICAL ANTIPSYCHOTICS, The Journal of clinical psychiatry, 59, 1998, pp. 46-52
Authors:
MALHOTRA A
BUCHANAN R
BREIER A
PICKEN L
PICKAR D
GOLDMAN D
Citation: A. Malhotra et al., ALLELIC VARIATION IN THE PROMOTER REGION OF THE DOPAMINE D-2 RECEPTORGENE INFLUENCES THE ANTIPSYCHOTIC RESPONSE TO CLOZAPINE, American journal of medical genetics, 81(6), 1998, pp. 477-478
Authors:
SANDERS AR
PAYLOR R
LIBBEY M
WANG J
CAO Q
ZHANG J
GOLDIN LR
PICKAR D
GERSHON ES
CRAWLEY JN
GEJMAN PV
Citation: Ar. Sanders et al., SUGGESTIVE EVIDENCE FOR A QUANTITATIVE TRAIT LOCUS ON CHROMOSOME-3 FOR PREPULSE INHIBITION IN THE MOUSE, American journal of medical genetics, 81(6), 1998, pp. 485-485
Authors:
ADLER CM
MALHOTRA AK
GOLDBERG T
PICKAR D
BREIER A
Citation: Cm. Adler et al., EFFECTS OF THE NMDA ANTAGONIST, KETAMINE ON FORMAL THOUGHT-DISORDER AND ON MEMORY IN HEALTHY-VOLUNTEERS, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 35196-35196
Authors:
ADLER CM
MALHOTRA AK
GOLDBERG T
ELMAN I
PICKAR D
BREIER A
Citation: Cm. Adler et al., COMPARISON OF KETAMINE-INDUCED AND SCHIZOPHRENIC THOUGHT-DISORDER, Biological psychiatry, 43, 1998, pp. 278-278
Authors:
ELMAN I
GASTFRIEND DR
ADLER CM
MALHOTRA AK
BIR C
PICKAR D
BREIER A
Citation: I. Elman et al., EFFECTS OF ACUTE METABOLIC STRESS ON PITUITARY-ADRENAL AXIS ACTIVATION IN PATIENTS WITH SCHIZOPHRENIA, Biological psychiatry, 43, 1998, pp. 415-415
Authors:
SU TP
PICKAR D
BREIER A
Citation: Tp. Su et al., DEXTROAMPHETAMINE-INDUCED NEUROCHEMICAL EFFECTS IN CHRONIC-SCHIZOPHRENICS AND HEALTHY-VOLUNTEERS, Biological psychiatry, 43, 1998, pp. 443-443